Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Innovex International Sees Q3 Sales $230.000M-$240.000M vs $217.000M Est

Author: Benzinga Newsdesk | August 05, 2025 03:33pm
Innovex International (NYSE:INVX) sees Q3 sales of $230.000 million-$240.000 million vs $217.000 million analyst estimate.

Posted In: INVX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist